Brief: European Medicines Agency Grants Orchard Therapeutics Accelerated Assessment Of OTL-200 For Patients With Metachromatic Leukodystrophy
18/11/2019 12:27
Nov 18 (Reuters) - Orchard Therapeutics PLC ORTX.O :
* EUROPEAN MEDICINES AGENCY GRANTS ORCHARD THERAPEUTICS
ACCELERATED ASSESSMENT OF OTL-200 FOR PATIENTS WITH
METACHROMATIC LEUKODYSTROPHY
* ORCHARD THERAPEUTICS - DECISION TO GRANT ACCELERATED
ASSESSMENT
HAS NO IMPACT ON EVENTUAL CHMP & CAT OPINION ON MARKETING
AUTHORIZATION
Source text for Eikon: ID:nGNX2FTC9T
Further company coverage: ORTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orchard Therapeutics
See all newsBrief: Orchard Therapeutics Says Court Of Justice Of England & Wales Sanctioned Scheme Of Arrangement Providing For Acquisition Of Co By Kyowa Kirin Co's Unit
Brief: Orchard Therapeutics Receives U.S. FDA Fast Track Designation For OTL-203 In MPS-IH
Brief: Orchard Therapeutics Says U.S. FDA Advised Co It Does Not Intend To Schedule Advisory Committee Meeting
Orchard Therapeutics rises on buyout deal by Japanese drugmaker
Kyowa Kirin to acquire Orchard Therapeutics for $478 mln